Active Ingredient: ENLICITIDE DECANOATE
Proprietary Name: LIPFENDRA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N220848
Product Number: 001
Approval Date: Jul 15, 2026
Applicant Holder Full Name: MERCK SHARP AND DOHME LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
